On June 23, 2011, FDA will hold a public meeting entitled Ultra High Throughput Sequencing for Clinical Diagnostic Applications—Approaches to Assess Analytical Validity.” The meeting will focus on validation methodologies, materials, and bioinformatics approaches needed to address unique analytical validation requirements of ultra high throughput sequencing based molecular diagnostics and confirm the sequencing quality and the accuracy of the tests.   Registration is required.